We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2014 by University of Zurich.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT01467440
First Posted: November 8, 2011
Last Update Posted: January 6, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Zurich
November 3, 2011
November 8, 2011
January 6, 2015
November 2011
December 2015   (Final data collection date for primary outcome measure)
IOP [ Time Frame: t0 ]
Not Provided
Complete list of historical versions of study NCT01467440 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines
Not Provided

Retrospective analysis of efficacy of selective laser trabeculoplasty in patients under treatment with topical prostaglandins compared to patients without topical prostaglandins is performed.

Inclusion criterion are patients with glaucoma or ocular hypertension, who underwent treatment with selective laser trabeculoplasty due to insufficient control of intraocular pressure during their routine treatment at the University Hospital Zurich / Division of Ophthalmology.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
glaucoma patients
  • Glaucoma
  • Ocular Hypertension
Device: Selective Laser Trabeculoplasty
trabeculoplasty with an SLT-Laser to reduce intraocular pressure
Other Name: SLT-Laser, Tango Laser, Ellex Medical Pty. Ltd., 82 Gilbert Street, Adelaide, SA 5000 Australia
  • PGA
    Patients under glaucoma treatment with prostaglandines
    Intervention: Device: Selective Laser Trabeculoplasty
  • NON-PGA
    Patient not recieving prostaglandines to treat their glaucoma
    Intervention: Device: Selective Laser Trabeculoplasty
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
200
December 2015
December 2015   (Final data collection date for primary outcome measure)

Inclusion criteria:

  • Patients with ocular hypertension or glaucoma who underwent selective laser trabeculoplasty due to insufficient control of intraocular pressure despite maximum tolerated topical treatment.

Exclusion criteria:

  • Optic neuropathy other than glaucoma
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
 
NCT01467440
SLT_PG_2011
Not Provided
Not Provided
Not Provided
University of Zurich
University of Zurich
Not Provided
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
Principal Investigator: Jens Funk, Professor, MD University Hospital Zurich, Ophtalmic Clinic
University of Zurich
December 2014